Search

everythinglearnresearchcommunity

for

Search:↓

Hormone therapy for trans individuals is effective and generally safe in the short term.

Overexpressing follistatin in mice delays wound healing and reduces scar size.

Testosterone therapy in transgender men has both desired effects like increased muscle mass and potential health risks such as higher cardiovascular risk.

Overexpressing a specific enzyme in mice causes hair loss and female infertility.

Testosterone treatment in trans men increases body and facial hair and may lead to hair loss over time, but severe skin issues are rare.

High levels of ODC and a mutant Ha-ras gene cause tumors in mice.

Uterine transplants for transgender women are feasible but need more research.

Hormonal treatment in transgender women reduces semen quality, but stopping treatment may improve it.

Hormone treatment for transgender patients may not need to be stopped before surgery, but more research is needed, especially on estrogen.

Testosterone therapy in transgender men can cause acne.

K6/ODC transgenic mice are effective for quickly identifying cancer-causing chemicals.

Excessive putrescine causes hair loss in transgenic mice by disrupting hair follicle development.

Hormone therapy and surgeries for transgender individuals affect their skin and hair, requiring specific dermatologic treatments and respectful care.

Overexpression of SSAT causes hair loss and skin issues, but reducing putrescine can help.

IGF-1 increases whisker growth in transgenic mice.

Early medical support for transgender youth is important for their health, with low regret for gender-affirming hormone use and a need for knowledgeable care providers.

Hormone therapy in transgender women can affect hair growth and acne, and there are specific skin issues related to gender-affirming surgery, but more research is needed on their dermatological health.

Bmpr2 and Acvr2a receptors are crucial for hair retention and color.

Hormonal therapy in transgender patients can lead to skin changes like altered sebum production, hair growth, and acne, which may require dermatological care.

Temporary ROS production in cultured human hair follicles promotes growth and stem cell activation.

Testosterone changes how certain channels work in male rat reproductive tracts, affecting fertility-related fluid balance.

Adding TERT and BMI1 to certain skin cells can improve their ability to create hair follicles in mice.

The document concludes that treatments for hair loss in transgender and gender-diverse individuals include topical solutions, oral medications, laser therapy, and hair restoration procedures, with progress assessed after 6-12 months.

Minoxidil can help transgender males grow facial hair before starting testosterone therapy.

Proper diagnosis is crucial to avoid overtreatment and complications in pregnant women with hyperthyroidism.

Parental support and gender-affirming care are crucial for the mental health of transgender adolescents.

Erythropoietin overexpression disrupts hair growth and fat formation in mice.

The treatment helped a transgender woman stop drinking, improved her mental health, and reduced her gender dysphoria.

Diagnosing osteoporosis in transgender people is challenging due to unclear guidelines and hormone treatment effects.